Treatment patterns in people with cystic fibrosis: have they changed since the introduction of ivacaftor?
Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First two Years of Life and Beyond
Management of Infants with Cystic Fibrosis: A Summary of the Evidence for the cystic Fibrosis Foundation Working Group on Care of Infants with Cystic Fibrosis